Synchron halts brain implant trials over component delays

A brain implant startup has halted clinical trials for its second-generation device, marking the first significant obstacle for a leader in a fast-growing industry. Synchron, headquartered in Brooklyn, New York, suspended testing after delays with one component, though the company stressed the issue did not involve safety concerns. The pause affects a system designed to help individuals with disabilities such as ALS or paralysis regain functional independence by converting brain signals into digital commands.
The company’s first-generation device uses a catheter to place a stent near the motor cortex, enabling users to operate devices through thought alone. The wireless upgrade was intended to streamline the procedure, but the delay has forced Synchron to reassess its development timeline. CEO Tom Oxley acknowledged the challenges during a recent industry conference in New York, where he noted the difficulty of coordinating hundreds of components in a medical device while managing regulatory approval processes.
Synchron’s decision to pause trials coincides with plans to reduce its workforce in New York City and shift focus toward a new device design. The move highlights the high stakes of commercializing brain-computer interfaces, where even minor setbacks can disrupt years of development. The company’s struggles also reveal how delicate the path to market approval remains, even for well-funded ventures with experienced leadership.
The stalled device relies on a catheter inserted into veins to position a stent near the brain’s motor cortex, allowing users to interact with digital interfaces through neural activity. This capability represents a major advance for those with severe motor impairments. The wireless version was meant to simplify the implantation process, but the pause demonstrates that even incremental improvements can encounter unexpected obstacles. Oxley’s remarks about regulatory delays show a persistent challenge in the field: brain-computer interfaces demand precise integration of hardware, software, and biological systems. A single delayed component—whether a sensor, battery, or connector—can stall the entire approval process, leaving companies in limbo while rivals make progress.
Teen-Led Movements Address Smartphone Addiction as Policy Lags
Teenagers are increasingly turning to self-directed initiatives to counter the harmful effects of excessive phone use, as formal policy responses and scientific research fail to keep pace. Programs modeled after recovery groups, such as those inspired by Alcoholics Anonymous, are helping young people develop strategies to reduce screen time and regain control over their attention. These efforts include public campaigns, written manifestos, and peer-led interventions aimed at reclaiming focus and supporting real-world connections.
Some initiatives also focus on exposing the financial and psychological mechanisms that drive digital addiction, encouraging teens to question the incentives behind their device use. The movement reflects a broader shift among young people toward prioritizing offline experiences and autonomy over constant digital engagement. While these grassroots approaches vary widely, they share a common goal of reclaiming personal freedom from technology dependency.
